
Turn Therapeutics Intranasal Vaccine Candidate Demonstrates Extended Stability
Turn Therapeutics announced promising stability data for its intranasal vaccine candidate, marking a significant step toward potentially reducing dependency on ultra-cold vaccine storage. The live,